Literature DB >> 10470273

Immune modulation by proteins secreted from cells infected by vaccinia virus.

G L Smith1, J A Symons, A Alcamí.   

Abstract

Vaccinia virus comprises the live vaccine that was used for vaccination against smallpox. Following the eradication of smallpox, vaccinia virus was developed as an expression vector that is now used widely in biological research and vaccine development. In recent years vaccinia virus and other poxviruses have been found to express a collection of proteins that block parts of the host response to infection. Some of these proteins are secreted from the infected cell where they bind and neutralise host cytokines, chemokines and interferons (IFN). In this paper three such proteins that bind interleukin (IL)-1 beta, type I IFNs and CC chemokines are described. The study of these immunomodulatory molecules is enhancing our understanding of virus pathogenesis, yielding fundamental information about the immune system, and providing new molecules that have potential application for the treatment of immunological disorders or infectious diseases.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10470273     DOI: 10.1007/978-3-7091-6425-9_8

Source DB:  PubMed          Journal:  Arch Virol Suppl        ISSN: 0939-1983


  10 in total

1.  Characterization of wild-type and mutant vaccinia virus M2L proteins' abilities to localize to the endoplasmic reticulum and to inhibit NF-kappaB activation during infection.

Authors:  Olivia Hinthong; Xiao-Lu Jin; Joanna L Shisler
Journal:  Virology       Date:  2008-01-10       Impact factor: 3.616

Review 2.  Initiation of primary anti-vaccinia virus immunity in vivo.

Authors:  Matthew A Fischer; Christopher C Norbury
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

3.  Deletion of specific immune-modulatory genes from modified vaccinia virus Ankara-based HIV vaccines engenders improved immunogenicity in rhesus macaques.

Authors:  David A Garber; Leigh A O'Mara; Sailaja Gangadhara; Monica McQuoid; Xiugen Zhang; Rui Zheng; Kiran Gill; Meena Verma; Tianwei Yu; Brent Johnson; Bing Li; Cynthia A Derdeyn; Chris Ibegbu; John D Altman; Eric Hunter; Mark B Feinberg
Journal:  J Virol       Date:  2012-09-12       Impact factor: 5.103

4.  Both carboxy- and amino-terminal domains of the vaccinia virus interferon resistance gene, E3L, are required for pathogenesis in a mouse model.

Authors:  T A Brandt; B L Jacobs
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

5.  Mature dendritic cells infected with herpes simplex virus type 1 exhibit inhibited T-cell stimulatory capacity.

Authors:  M Kruse; O Rosorius; F Krätzer; G Stelz; C Kuhnt; G Schuler; J Hauber; A Steinkasserer
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

6.  Viral infection causes a shift in the self peptide repertoire presented by human MHC class I molecules.

Authors:  Charles T Spencer; Jelena S Bezbradica; Mireya G Ramos; Chenoa D Arico; Stephanie B Conant; Pavlo Gilchuk; Jennifer J Gray; Mu Zheng; Xinnan Niu; William Hildebrand; Andrew J Link; Sebastian Joyce
Journal:  Proteomics Clin Appl       Date:  2015-12       Impact factor: 3.494

7.  Encephalitis after secondary smallpox vaccination.

Authors:  Vlada V Melekhin; Kevin L Karem; Inger K Damon; Karen C Bloch
Journal:  Clin Infect Dis       Date:  2009-01-01       Impact factor: 9.079

Review 8.  Role of trophic factors on neuroimmunity in neurodegenerative infectious diseases.

Authors:  Dianne Langford; Eliezer Masliah
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 3.739

9.  Predicting the subcellular localization of viral proteins within a mammalian host cell.

Authors:  M S Scott; R Oomen; D Y Thomas; M T Hallett
Journal:  Virol J       Date:  2006-04-04       Impact factor: 4.099

10.  T cell inactivation by poxviral B22 family proteins increases viral virulence.

Authors:  Dina Alzhanova; Erika Hammarlund; Jason Reed; Erin Meermeier; Stephanie Rawlings; Caroline A Ray; David M Edwards; Ben Bimber; Alfred Legasse; Shannon Planer; Jerald Sprague; Michael K Axthelm; David J Pickup; David M Lewinsohn; Marielle C Gold; Scott W Wong; Jonah B Sacha; Mark K Slifka; Klaus Früh
Journal:  PLoS Pathog       Date:  2014-05-15       Impact factor: 6.823

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.